Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.51
Delayed Data
As of May 27
 +0.31 / +2.35%
Today’s Change
7.31
Today|||52-Week Range
14.07
+62.77%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close13.20
Today’s open13.25
Day’s range13.10 - 13.51
Volume891,451
Average volume (3 months)786,115
Market cap$630.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-57.03%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio19.2
Price/Sales2.87
Price/Book7.95

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.03+0.52%
INFIInfinity Pharmaceuti...+0.10+0.77%
OREXOrexigen Therapeutic...-0.02-0.30%
DVAXDynavax Technologies...+0.31+1.41%
Data as of 4:00pm ET, 05/27/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers